Alpha-Galactosidase 用于 肠易激综合征(IBS)
D 研究 目前仅存在初步研究(实验室研究、病例报告)。Single study in IBS patients consuming high-FODMAP diet. May reduce gas-related symptoms from specific food triggers.
结论
Single study in IBS patients consuming high-FODMAP diet. May reduce gas-related symptoms from specific food triggers.
Key Study Findings
研究人群: None
研究人群: patients with ibs after three standardized
研究人群: IBS patients (Rome III, H2 producers)
研究人群: IBS patients
Key Statistics
1
研究数量
60
受试者
Positive
等级
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- general:
- 150-300 GalU (alpha-galactosidase units) per serving of gas-producing foods
- standardbeanodose:
- 300 GalU (2-3 tablets) with first bite of problem food
上限: No established upper limit; adjust per meal as needed
研究中使用的剂量
| 剂量 | 持续时间 | 效果 | N |
|---|---|---|---|
| None | -- | Mixed | -- |
| 1200 G | -- | Neutral | -- |
| 300 GALU or 150 GALU | 2.0 weeks | Positive | 31 |
| alpha-galactosidase 600 GalU per meal | 4 weeks | Neutral | 125 |
最佳服用时间: With the first bite of gas-producing food
Safety & Side Effects
已报告的副作用
- ⚠ Generally very well-tolerated
- ⚠ Rare allergic reactions to mold-derived enzyme (Aspergillus source)
- ⚠ May cause mild GI discomfort in rare cases
已知相互作用
- ● Acarbose (alpha-galactosidase may counteract the blood sugar-lowering mechanism of acarbose; contraindicated for concurrent use)
- ● Miglitol (similar mechanism conflict as acarbose)
可耐受最高摄入量: No established upper limit; adjust per meal as needed
在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does Alpha-Galactosidase help with 肠易激综合征(IBS)?
How much Alpha-Galactosidase should I take for 肠易激综合征(IBS)?
Are there side effects of Alpha-Galactosidase?
How strong is the evidence for Alpha-Galactosidase and 肠易激综合征(IBS)?
Related Evidence
其他成分用于 肠易激综合征(IBS)
Alpha-Galactosidase 用于其他健康状况
References
- [1] Fabio Caputo et al.. Int J Environ Res Public Health. 2021. Gastrointestinal Involvement in Anderson-Fabry Disease: A Narrative Review. doi:10.3390/ijerph18063320 PubMed
- [2] Lena Böhn et al.. Neurogastroenterol Motil. 2021. A randomized double-blind placebo-controlled crossover pilot study: Acute effects of the enzyme α-galactosidase on gastrointestinal symptoms in irritable bowel syndrome … doi:10.1111/nmo.14094 PubMed
- [3] C J Tuck et al.. Am J Gastroenterol. 2018. Increasing Symptoms in Irritable Bowel Symptoms With Ingestion of Galacto-Oligosaccharides Are Mitigated by α-Galactosidase Treatment. doi:10.1038/ajg.2017.245 PubMed
- [4] Markku Hillilä et al.. Scand J Gastroenterol. 2016. Does oral α-galactosidase relieve irritable bowel symptoms? doi:10.3109/00365521.2015.1063156 PubMed
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。